(VIANEWS) - DENTSPLY SIRONA (XRAY), ePlus (PLUS), TTEC Holdings (TTEC) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. DENTSPLY SIRONA (XRAY)
22.5% sales growth and 7.59% return on equity
DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide.
DENTSPLY SIRONA's sales growth this year is expected to be 28.4% and 5.1% for next year.
Year-on-year quarterly revenue growth grew by 117.3%, now sitting on 4.07B for the twelve trailing months.
Volume
Today's last reported volume for DENTSPLY SIRONA is 831368 which is 33.99% below its average volume of 1259460.
DENTSPLY SIRONA's sales growth for the next quarter is 22.5%. The company's growth estimates for the ongoing quarter and the next is 461.1% and negative -3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.59%.
Volatility
DENTSPLY SIRONA's last day, last week, and last month's current volatility was 0.03%, 1.25%, and 1.38%, respectively.
DENTSPLY SIRONA's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.28% (day), 2.03% (last week), and 2.20% (last month), respectively.
DENTSPLY SIRONA's Stock Yearly Top and Bottom Value
DENTSPLY SIRONA's stock is valued at $59.86 at 20:22 EST, way below its 52-week high of $69.54 and way higher than its 52-week low of $41.52.
DENTSPLY SIRONA's Moving Average
DENTSPLY SIRONA's value is under its 50-day moving average of $62.24 and under its 200-day moving average of $62.77.2. ePlus (PLUS)
18.1% sales growth and 14.17% return on equity
ePlus inc., through its subsidiaries, provides information technology solutions that enable organizations to optimize their information technology (IT) environment and supply chain processes in the United States.
ePlus's sales growth this year is expected to be 8.6% and 5% for next year.
Year-on-year quarterly revenue growth declined by 0.3%, now sitting on 1.58B for the twelve trailing months.
Volume
Today's last reported volume for ePlus is 75904 which is 3.06% above its average volume of 73646.
ePlus's sales growth for the next quarter is 18.1%. The company's growth estimates for the present quarter and the next is 2.6% and 26.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.17%.
Volatility
ePlus's last day, last week, and last month's current volatility was 0.54%, 0.59%, and 1.15%, respectively.
ePlus's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.39% (day), 2.33% (last week), and 2.63% (last month), respectively.
ePlus's Stock Yearly Top and Bottom Value
ePlus's stock is valued at $108.04 at 20:22 EST, under its 52-week high of $108.61 and way above its 52-week low of $66.91.
ePlus's Moving Average
ePlus's worth is way higher than its 50-day moving average of $92.18 and way higher than its 200-day moving average of $95.13.3. TTEC Holdings (TTEC)
15.5% sales growth and 32.78% return on equity
TTEC Holdings, Inc., a customer experience technology and services company, focuses on the design, implementation, and delivery of transformative customer experience for various brands.
TTEC Holdings's sales growth this year is anticipated to be 15.8% and 9.9% for next year.
Year-on-year quarterly revenue growth grew by 22.4%, now sitting on 2.16B for the twelve trailing months.
Volume
Today's last reported volume for TTEC Holdings is 128739 which is 16.64% above its average volume of 110366.
TTEC Holdings's sales growth for the next quarter is 15.5%. The company's growth estimates for the present quarter and the next is 29.3% and negative -5.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 32.78%.
Volatility
TTEC Holdings's last day, last week, and last month's current volatility was 3.12%, 1.67%, and 1.48%, respectively.
TTEC Holdings's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.32% (day), 2.59% (last week), and 2.80% (last month), respectively.
TTEC Holdings's Stock Yearly Top and Bottom Value
TTEC Holdings's stock is valued at $104.32 at 20:22 EST, below its 52-week high of $113.15 and way above its 52-week low of $51.29.
TTEC Holdings's Moving Average
TTEC Holdings's value is higher than its 50-day moving average of $102.65 and above its 200-day moving average of $99.13.4. First Guaranty Bancshares (FGBI)
13.4% sales growth and 11.55% return on equity
First Guaranty Bancshares, Inc. operates as the holding company for First Guaranty Bank that provides commercial banking services in Louisiana and Texas.
First Guaranty Bancshares's sales growth this year is expected to be 13% and 7% for next year.
Year-on-year quarterly revenue growth grew by 18.8%, now sitting on 89.6M for the twelve trailing months.
Volume
Today's last reported volume for First Guaranty Bancshares is 7649 which is 58.14% below its average volume of 18273.
First Guaranty Bancshares's sales growth is a negative 0% for the present quarter and 13.4% for the next. The company's growth estimates for the current quarter and the next is 26.2% and 8.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.55%.
Volatility
First Guaranty Bancshares's last day, last week, and last month's current volatility was 1.46%, 0.88%, and 0.68%, respectively.
First Guaranty Bancshares's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.73% (day), 1.87% (last week), and 1.20% (last month), respectively.
First Guaranty Bancshares's Stock Yearly Top and Bottom Value
First Guaranty Bancshares's stock is valued at $19.15 at 20:22 EST, way under its 52-week high of $21.29 and way higher than its 52-week low of $11.54.
First Guaranty Bancshares's Moving Average
First Guaranty Bancshares's value is below its 50-day moving average of $19.18 and above its 200-day moving average of $18.39.5. AbbVie (ABBV)
11.5% sales growth and 48.86% return on equity
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally.
AbbVie's sales growth this year is expected to be 23.1% and 6.1% for next year.
Year-on-year quarterly revenue growth grew by 33.9%, now sitting on 53.73B for the twelve trailing months.
Volume
Today's last reported volume for AbbVie is 5092120 which is 16.34% below its average volume of 6087230.
AbbVie's sales growth for the next quarter is 11.5%. The company's growth estimates for the ongoing quarter and the next is 32.1% and 14.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 48.86%.
Volatility
AbbVie's last day, last week, and last month's current volatility was 0.27%, 0.81%, and 0.83%, respectively.
AbbVie's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.10% (day), 1.68% (last week), and 1.48% (last month), respectively.
AbbVie's Stock Yearly Top and Bottom Value
AbbVie's stock is valued at $120.40 at 20:22 EST, under its 52-week high of $121.40 and way above its 52-week low of $79.11.
AbbVie's Moving Average
AbbVie's value is above its 50-day moving average of $116.83 and higher than its 200-day moving average of $112.03.Previous days news about AbbVie(ABBV)
- According to Business Insider on Saturday, 21 August, "It sold around $260 million of AbbVie stock, $307 million of Bristol Myers Squibb stock, and $645 million of Merck stock, based on the companies' average closing share prices in the period.", "Yet Berkshire turned around and sold roughly $2.4 billion worth of pharma stocks in the first six months of this year, slashing its AbbVie and Bristol Myers Squibb stakes by about 20% and its Merck position by 68%."
6. Elbit Systems Ltd. (ESLT)
11.1% sales growth and 11.14% return on equity
Elbit Systems Ltd.
Elbit Systems Ltd.'s sales growth this year is expected to be 7.7% and 5.1% for next year.
Year-on-year quarterly revenue growth grew by 20.7%, now sitting on 4.93B for the twelve trailing months.
Volume
Today's last reported volume for Elbit Systems Ltd. is 171175 which is 275.64% above its average volume of 45568.
Elbit Systems Ltd.'s sales growth for the next quarter is 11.1%. The company's growth estimates for the current quarter and the next is 0.6% and 2.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.14%.
Volatility
Elbit Systems Ltd.'s last day, last week, and last month's current volatility was 0.16%, 0.71%, and 1.59%, respectively.
Elbit Systems Ltd.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.14% (day), 1.94% (last week), and 1.85% (last month), respectively.
Elbit Systems Ltd.'s Stock Yearly Top and Bottom Value
Elbit Systems Ltd.'s stock is valued at $145.83 at 20:22 EST, below its 52-week high of $147.22 and way higher than its 52-week low of $110.69.